Navigation Links
Dr Reddys Launches New Drug In Its Urology Segment

Consolidating its position in the urology segment, pharma major Dr Reddys Laboratories Ltd has introduced a drug Alfuzosin Hydrochloride available// in extended release tablets of 10 mg dosage.

Alfuzosin Hydrochloride, introduced under the brand name 'Alfoo' is indicated for treatment of enlargement of prostate gland in ageing men known as Benign Prostatic Hyperplasia (BPH), a company release said.

The product was launched nationwide, and would further help the company consolidate its position in the urology segment which has over 10 products in the urology segment, the company informed the Bombay Stock Exchange.

The product is now available in over 5,700 retail counters across the nation and marketed by over 100 scientific business officers, it added.

The market size for the product as per April 2006 market data is valued at Rs 27 crore and the urology segment is estimated at Rs 65.08 crore.

Alfuzosin provides rapid relief from signs and symptoms of Benign Prostatic Hyperplasia (BPH) is a most common disorder among ageing men. The prevalence of BPH increases from 8 per cent in men between 31 and 40 years of age to 50 per cent in men between 51 and 60 years of age.

The shares of the company were trading at Rs 1,274.95, 0.07 per cent at the BSE

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. Serum Institute Launches New Tetanus-Diphtheria Vaccine
3. Scottish Health Minister Launches Organ Donor Plan
4. Pfizer Launches Viagra For Lung Disease In UK
5. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
6. PM Launches Healthcare Foundation For India
7. African Union Launches A Programme On Acceleration of HIV Prevention
8. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
9. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
10. The British Medical Journal Launches A Health Website
11. APEC Launches Bird Flu Exercise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel ... the Food Bank of Eastern Michigan last Friday in order to aid in the ... the Midwest to include a facility located in Clio, only 15 miles away from ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting ... Healthcare, recently partnered with Heart City Health Center to improve access ... years, Heart City Health Center has provided the Elkhart community with access to ...
(Date:2/10/2016)... , ... February 10, 2016 , ... 10 Best ... There were three leading bottled water brand owners that topped the list as a ... connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch water ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors ... the latest addition to its growing list of Partner Firms. S.S. Nesbitt ... from Orlando to Huntsville and in between. , Harnessing the experience and insights ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... MINNEAPOLIS , Feb. 10, 2016 Urologix, ... for the treatment of Benign Prostatic Hyperplasia (BPH), announces ... Ash Keswani , a medical device industry veteran ... of the Limited Liability Company.  ... and service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, ...
(Date:2/10/2016)... Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko ... completed, through its indirect wholly-owned subsidiary Laurel Acquisition Inc. ... outstanding shares of common stock of Ocata Therapeutics, Inc. ... "Ocata") for a price of US$8.50 per share net ... the Tender Offer on November 19, 2015, U.S. Eastern ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology: